These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Strategy and alternate randomized designs in cancer clinical trials. Zelen M Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213 [No Abstract] [Full Text] [Related]
23. Philosophy on trial: examining ethics of clinical investigations. Marwick C JAMA; 1988 Aug; 260(6):749-51. PubMed ID: 3392800 [No Abstract] [Full Text] [Related]
24. Medical ethics and controlled clinical trials. Klein JO Ann Otol Rhinol Laryngol; 1979 Part 2): 99-106, Sep-Oct; 88(5):. PubMed ID: 11662786 [No Abstract] [Full Text] [Related]
25. Ethics of clinical research: lessons for the future. Baum M; Zilkha K; Houghton J BMJ; 1989 Jul; 299(6693):251-3. PubMed ID: 2504385 [No Abstract] [Full Text] [Related]
26. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. Avins AL J Med Ethics; 1998 Dec; 24(6):401-8. PubMed ID: 9873981 [TBL] [Abstract][Full Text] [Related]
27. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. Daugherty CK J Clin Oncol; 1999 May; 17(5):1601-17. PubMed ID: 10334550 [TBL] [Abstract][Full Text] [Related]
28. Randomised trials and informed consent. Brahams D Lancet; 1988 Oct; 2(8618):1033-4. PubMed ID: 2902486 [TBL] [Abstract][Full Text] [Related]
29. Suspended judgment. Clinical trials of informed consent. Simel DL; Feussner JR Control Clin Trials; 1992 Oct; 13(5):321-4. PubMed ID: 1330436 [No Abstract] [Full Text] [Related]
31. A desperate solution: individual autonomy and the double-blind controlled experiment. Logue G; Wear S J Med Philos; 1995 Feb; 20(1):57-64. PubMed ID: 7738459 [TBL] [Abstract][Full Text] [Related]
32. How to resolve an ethical dilemma concerning randomized clinical trials. Marquis D N Engl J Med; 1999 Aug; 341(9):691-3. PubMed ID: 10460824 [No Abstract] [Full Text] [Related]
33. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. Ratain MJ; Mick R; Schilsky RL; Siegler M J Natl Cancer Inst; 1993 Oct; 85(20):1637-43. PubMed ID: 8411243 [No Abstract] [Full Text] [Related]
35. Better safe than sorry. Faulder C Bull Med Ethics; 1992 Feb; No. 75():29-33. PubMed ID: 11651270 [No Abstract] [Full Text] [Related]
36. Protecting the scientific integrity of a clinical trial: some ethical dilemmas. Howard J; Friedman L Clin Pharmacol Ther; 1981 May; 29(5):561-9. PubMed ID: 7214785 [TBL] [Abstract][Full Text] [Related]
37. The use of placebos in randomized clinical trials. Levine RJ; Schafer A IRB; 1985; 7(2):1-6. PubMed ID: 11649622 [No Abstract] [Full Text] [Related]
39. Statistics and ethics in medical research: study design. Altman DG Br Med J; 1980 Nov; 281(6250):1267-9. PubMed ID: 7000298 [No Abstract] [Full Text] [Related]